Skip to main content

Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · IEX Real-Time Price · USD
10.55
+0.07 (0.72%)
Nov 30, 2023, 11:43 AM EST - Market open

Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of $525.12 million as of November 30, 2023. Its market cap has decreased by -24.97% in one year.

Market Cap
525.12M
Enterprise Value
437.38M
1-Year Change
-24.97%
Ranking
#2869
Category
Small-Cap
Stock Price
$10.55

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $525.12M, a decrease of -29.11%. That is a compound annual growth rate of -3.54%.

History

DateMarket Cap% Change
Nov 29, 2023521.40M
0.87%
Nov 28, 2023516.90M
-1.15%
Nov 27, 2023522.90M
0.29%
Nov 24, 2023521.40M
0.97%
Nov 22, 2023516.40M
0.88%
Nov 21, 2023511.90M
-0.87%
Nov 20, 2023516.40M
-0.77%
Nov 17, 2023520.40M
1.56%
Nov 16, 2023512.40M
0.59%
Nov 15, 2023509.40M
-0.68%
Nov 14, 2023512.90M
0.98%
Nov 13, 2023507.90M
0.97%
Nov 10, 2023503.00M
0.30%
Nov 9, 2023501.50M
-7.35%
Nov 8, 2023541.30M
5.33%
Nov 7, 2023513.90M
-2.39%
Nov 6, 2023526.50M
1.21%
Nov 3, 2023520.20M
0.72%
Nov 2, 2023516.50M
-0.31%
Nov 1, 2023518.10M
3.91%
Oct 31, 2023498.60M
1.51%
Oct 30, 2023491.20M
3.00%
Oct 27, 2023476.90M
-2.27%
Oct 26, 2023488.00M
0.23%
Oct 25, 2023486.90M
-0.65%
View and export this data all the way back to 2014. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
OmniAb 531.21M
IRadimed 529.64M
ModivCare 528.60M
Enhabit 528.37M
Atrion 527.74M
SomaLogic 520.96M
Biomea Fusion 520.68M
Caribou Biosciences 519.53M
Market Cap Rankings